- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Colonial Foundation Healthy Ageing Centre

- Our work: An early blood test for dementia
- The problem
- The solution
- Our goals
- Who we are
- Our research projects
- Contact us
The Colonial Foundation Healthy Ageing Centre was established as a collaboration between founding partners WEHI and the Royal Melbourne Hospital, and made possible thanks to a generous $15 million commitment from the Colonial Foundation.
Our work: An early blood test for dementia
The Colonial Foundation Healthy Ageing Centre has a single focus – to design and develop the first blood test to diagnose dementia. The test will diagnose dementia at an early stage, when more can be done to stop or slow the progression of the disease.
Over the five-year term of the centre, we will use cutting-edge technology and bioinformatic tools to analyse more than 20,000 human samples with the aim of identifying a dementia signature. With clinical pathologists at the Royal Melbourne Hospital (RMH), we will validate biomarkers with the goal of developing pathology tests for the early detection of dementia. A diagnostic test will also help to:
- monitor disease progression
- monitor treatment response
- assist clinicians in prescribing targeted interventions
- better understand familial risk.

The problem
Dementia is a complex and growing health problem. It is a progressive neurological condition that will touch many of our lives. Living with dementia can profoundly impact a person’s quality of life, and families acting as carers.
Despite dementia being the second leading cause of death in Australia, research continues to be underfunded. Without a medical breakthrough, the number of people living with dementia is expected to more than double by 2050.
Dementia research has so far failed to deliver life-changing benefits for individuals and the community in the same way that new treatments for cancer or heart disease have.
The solution
We urgently need new and better ways to diagnose dementia. These solutions must take advantage of the most advanced technologies available while being accurate, cost-effective and practical enough to be widely used.
The Colonial Foundation Healthy Ageing Centre has:
- A collaborative vision to bring together the best and brightest minds to tackle one of the biggest global health crises.
- A different approach, using state-of-the-art mass spectrometry technology to find complex disease signatures that will enable early detection of dementia.
- A unique network of medical researchers, clinicians, neuropsychiatrists, pathologists, patient advocacy groups and philanthropists, working together to make this vision a reality.
Our goals
Stage 1: Discover biomarkers
We are generating proteomic and metabolic data to identify a biomarker or panel of biomarkers that could be used to detect and diagnose dementia.
Stage 2: Develop assays for emerging biomarkers
The centre is developing immunoassays for ultrasensitive detection of blood biomarkers for dementia.
Stage 3: Implement tests in pathology labs
We are addressing the challenges of implementing powerful mass spectrometry-based tools for diagnostics, to produce an accredited pathology test for the early detection of dementia.
Stage 4: Conduct patient data-driven research
We are investigating Parkinson's disease biomarkers and optimising tools for biomarker discovery.
Our collaborators
Who we are
|
|
Frank is the former Director of Pathology at the Royal Melbourne Hospital and has been instrumental in establishing the Colonial Foundation Healthy Ageing Centre as a partnership between WEHI and the Royal Melbourne Hospital. Frank is a member of the National Pathology Accreditation Advisory Council (NPAAC) and an assessor of pathology laboratories for NATA (National Association of Testing Authorities). His work includes translational research, pathology services and laboratory medicine in the fields of genomics, proteomics and metabolomics. |
|
|
The Centre brings together an interdisciplinary team of researchers, clinicians and pathologists who are highly skilled in proteomics technologies, data analysis and clinical assay development.

From left to right: Dr Steve Binos, Dr Mustafa Ayha, Sukhdeep Spall, Dr Jeffrey Smith, A/Prof Andrew Webb, Dr Nadja Bertleff-Zieschang,
Dr Ahmed Mohamed, A/Prof Cherie Chiang, Dr Sylvie Callegari, Kruti Patel, Julian Kelabora.
Not pictured: Dolores Arenas Cavero, Dr Joel Smith, Dr Simon Cobbold.
Our research projects
The Colonial Foundation Healthy Ageing Centre has a single focus – to develop new and better ways to diagnose and treat dementia. The five-year centre will:
-
Discover biomarkers
Together with the ASPREE team at Monash University, we are generating proteomic and metabolic data to identify a biomarker or panel of biomarkers that could be used to detect and diagnose dementia.
The centre uses an approach called mass spectrometry (MS)-based proteomics to study – in unprecedented detail and complexity – the nature of healthy ageing and disease.
We are creating the technology needed to undertake this work; the first step in this ambitious program. We will use this technology to analyse blood and urine samples from 12,000 healthy individuals collected from the ASPREE study over more than a decade. More than 1000 people in this study have since been diagnosed with dementia, giving us an unparalleled opportunity to identify early signs of dementia.
Project team
- Dolores Arenas Cavero
- Dr Steve Binos
- Julian Kelabora
- Dr Ahmed Mohamed
- Sukhdeep Spall
-
Develop assays for emerging biomarkers
The centre is developing immunoassays for ultrasensitive detection of blood biomarkers for dementia.
The first candidate selected was the neurofilament light chain (NfL), a marker for neurological damage. We are collaborating with Professor Dennis Velakoulis and his team at The Royal Melbourne Hospital (RMH) Neuropsychiatry, who have extensive experience in clinical diagnosis of neurological disorders and clinical research into NfL.
They demonstrated that NfL levels are elevated in plasma from patients with neurodegenerative disorders, including Alzheimer's and Parkinson's diseases, both of which are associated with dementia. There is a strong and unmet clinical need for detection of NfL and other emerging biomarkers, and the focus of this work is to develop a robust and clinically suitable assay for use in routine pathology.
Project team
- Jeff Smith
- Kruti Patel
-
Implement tests in pathology labs
Together with clinical pathologists at the Royal Melbourne Hospital, we will address the challenges of implementing these powerful tools for diagnostics, to produce an accredited pathology test for the early detection of dementia. In a first step, we are building mass spectrometry capacity and knowledge in Melbourne Health Pathology so that state-of-the-art technology can be translated to the clinic.
Currently, work is continuing at RMH Pathology to increase the number of Therapeutic Drug Monitoring (TDM) tests developed on site and provided to clinicians and patients using cutting-edge mass spectrometry instrumentation. With hospital clinicians, a list of therapeutic drugs was compiled for which patient monitoring was a top priority. The first was the azole antifungals. The development and bioanalytical method validation is nearing completion and we anticipate routine testing for these antifungal drugs will begin early in 2022. Every routine diagnostic test that is developed on site will build mass spectrometry-based capability and knowledge within RMH to facilitate the validation and test implementation of the newer proteomics-based testing in the future.
Project team
- Dr Mustafa Ayhan
- Dr Joel Smith
-
Patient data-driven research
The centre studies the hypothesis that selected proteins play a role in pathways leading to Parkinson's disease making them not only potential biomarker of disease, but also candidate drug targets.
We also strive to optimise current sample purification protocols and mass spectrometry data analysis including artificial intelligence-assisted tools to increase sensitivity and identification of biomarker in our data.
Project team
- Dr Sylvie Callegari
- Dr Simon Cobbold
- Sukhdeep Spall
- Daryl Wilding-McBride
Contact us
Enquiries can be sent to Dr Nadja Bertleff-Zieschang, Colonial Foundation Healthy Ageing Centre Manager.